Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC

Se Hoon Lee; June Koo Lee

doi:10.1016/S2213-2600(17)30010-3

Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC

Se Hoon Lee
, June Koo Lee

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e10
Journal	The Lancet Respiratory Medicine
Volume	5
Issue number	2
DOIs	https://doi.org/10.1016/S2213-2600(17)30010-3
State	Published - 1 Feb 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2213-2600(17)30010-3

Cite this

@article{1bd9fb5625074ec683e3504e29fc2527,

title = "Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC",

author = "Lee, \{Se Hoon\} and Lee, \{June Koo\}",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/S2213-2600(17)30010-3",

language = "English",

volume = "5",

pages = "e10",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC

AU - Lee, Se Hoon

AU - Lee, June Koo

PY - 2017/2/1

Y1 - 2017/2/1

UR - https://www.scopus.com/pages/publications/85010886975

U2 - 10.1016/S2213-2600(17)30010-3

DO - 10.1016/S2213-2600(17)30010-3

M3 - Letter

C2 - 28145234

AN - SCOPUS:85010886975

SN - 2213-2600

VL - 5

SP - e10

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 2

ER -

Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC

UN SDGs

Access to Document

Other files and links

Cite this